Iron Supplements: When Women Need Them—and When They Do Not

Iron helps the body make hemoglobin, the protein in red blood cells that carries oxygen. Iron deficiency can develop before anemia appears, and untreated deficiency may contribute to fatigue, weakness, reduced exercise tolerance, or other symptoms. But iron is not a general-purpose energy supplement: taking it without a reason can cause gastrointestinal problems, interact with medicines, and, in large amounts, cause serious poisoning. ([NIH Office of Dietary Supplements](https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/); [NIH Office of Dietary Supplements—Consumer](https://ods.od.nih.gov/factsheets/Iron-Consumer/))

The concise answer

Having periods does not, by itself, mean you should take iron. Menstrual blood loss raises the possibility of iron depletion, particularly when bleeding is heavy or prolonged, but the appropriate next step is usually to assess risk and consider testing rather than automatically starting a supplement. The same principle applies to fatigue: symptoms can justify evaluation, but they do not diagnose iron deficiency.

Iron supplementation is more clearly appropriate when laboratory results support iron deficiency or iron-deficiency anemia, when a clinician identifies a meaningful risk of deficiency, or when pregnancy care includes a prenatal or therapeutic iron recommendation. A common starting evaluation is a complete blood count, often with ferritin. Additional testing may be needed when inflammation, chronic disease, kidney disease, malabsorption, inherited blood disorders, or another cause of anemia is possible. ([AGA guideline](https://gastro.org/press-releases/aga-recommends-bidirectional-endoscopy-for-most-patients-with-iron-deficiency-anemia-2/); [WHO ferritin guidance](https://www.who.int/tools/elena/interventions/ferritin-concentrations))

Pregnancy deserves separate discussion. Iron requirements increase during pregnancy, and ACOG recommends anemia screening at the first prenatal visit and again at 24–28 weeks. ACOG also describes low-dose iron supplementation as part of pregnancy care and recommends additional treatment when iron-deficiency anemia is diagnosed. Separately, the U.S. Preventive Services Task Force issued an I statement on August 20, 2024, concluding that evidence is insufficient to determine the benefits and harms of routine screening or supplementation for asymptomatic pregnant people. That finding does not advise people with symptoms, anemia, or diagnosed deficiency to avoid treatment. ([ACOG](https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2021/08/anemia-in-pregnancy); [USPSTF](https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/iron-deficiency-anemia-in-pregnant-women-screening-and-supplementation))

Five key takeaways

1. Menstruation increases risk; it does not prove deficiency. Heavy bleeding, a restrictive diet, frequent blood donation, impaired absorption, or another source of blood loss can change the decision.

2. Ferritin is useful but context matters. Low ferritin supports depleted iron stores, while inflammation and some chronic illnesses can make ferritin appear higher than the available iron stores actually are.

3. Normal hemoglobin does not always exclude iron deficiency. Iron stores may fall before anemia develops, although treating low ferritin without anemia should be individualized rather than based on a universal target.

4. Pregnancy care is not the same as self-prescribing high-dose iron. Prenatal supplementation, evaluation of anemia, and treatment of confirmed deficiency are related but distinct decisions.

5. Oral iron can help, but side effects and overdose risk are real. Keep iron-containing products away from children and seek medical advice for persistent symptoms, unexplained bleeding, or abnormal results.

Why menstruation changes the calculation

Menstrual bleeding is one of several ways the body loses iron. Many women replace that loss through food. Others gradually deplete their iron stores, especially when bleeding is heavy, dietary intake is low, or absorption is impaired. Young women with iron-deficiency anemia commonly have more than one contributing factor, including menstrual losses, pregnancy, or inadequate dietary intake. ([British Society of Gastroenterology guideline](https://pmc.ncbi.nlm.nih.gov/articles/PMC8515119/))

Heavy menstrual bleeding is not defined only by a person’s estimate of blood volume. The CDC lists periods lasting more than seven days, needing a new pad or tampon in less than two hours, or passing large clots as warning signs. Heavy or prolonged bleeding can contribute to anemia and deserves evaluation for its cause rather than treatment with iron alone. ([CDC](https://www.cdc.gov/female-blood-disorders/about/heavy-menstrual-bleeding.html))

Potential contributors to iron deficiency include:

• Heavy, prolonged, or frequent menstrual bleeding.
• A diet low in iron-containing foods, including some restrictive or poorly planned diets.
• Frequent blood donation.
• Conditions that impair absorption, such as celiac disease, inflammatory bowel disease, or gastrointestinal surgery.
• Chronic gastrointestinal blood loss.
• Medicines or conditions that increase bleeding risk.
• Pregnancy or closely spaced pregnancies.
• An inherited blood disorder or another illness that causes anemia but will not improve simply by taking more iron.

Bleeding between periods, bleeding after sex, or any new bleeding after menopause should not be managed with iron alone. These patterns can have gynecologic, hormonal, medication-related, structural, or other causes and warrant medical assessment.

For adolescents with heavy menstrual bleeding, ACOG recommends assessment for anemia, including serum ferritin, along with evaluation for endocrine causes and possible bleeding disorders when indicated. ACOG also states that iron replacement should be provided for reproductive-aged patients with anemia caused by bleeding. ([ACOG](https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/09/screening-and-management-of-bleeding-disorders-in-adolescents-with-heavy-menstrual-bleeding))

What ferritin and hemoglobin can—and cannot—tell you

A complete blood count measures hemoglobin and red-cell indices. Low hemoglobin confirms anemia according to the laboratory’s reference range, but anemia has many possible causes. Mean corpuscular volume may support iron deficiency when it is low, but it is not specific enough to diagnose every case.

Ferritin reflects stored iron and is often the most useful single marker of iron stores. A clearly low value strongly supports iron deficiency. However, ferritin also rises with inflammation, infection, liver disease, and other conditions. WHO therefore recommends interpreting ferritin with attention to inflammation and the person’s clinical condition rather than treating one number as definitive. ([WHO ferritin guidance](https://www.who.int/tools/elena/interventions/ferritin-concentrations))

There is no single ferritin threshold that determines supplementation for every woman. The NIH Office of Dietary Supplements notes that ferritin below about 30 micrograms per liter often suggests deficiency in otherwise healthy people, while the American Gastroenterological Association recommends a cutoff below 45 nanograms per milliliter when diagnosing iron deficiency in adults who already have anemia. These thresholds address different clinical contexts and should not be converted into an online “optimal ferritin” target for everyone. ([NIH ODS](https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/); [AGA guideline](https://gastro.org/press-releases/aga-recommends-bidirectional-endoscopy-for-most-patients-with-iron-deficiency-anemia-2/))

When ferritin is borderline or inflammation is possible, clinicians may use transferrin saturation, serum iron, C-reactive protein, soluble transferrin receptor, reticulocyte hemoglobin, or other tests. A high ferritin does not automatically mean iron overload, and WHO cautions against using ferritin alone to diagnose excess iron. ([WHO guideline PDF](https://iris.who.int/bitstream/handle/10665/331505/9789240000124-eng.pdf))

When supplementation is more likely to make sense

Confirmed iron deficiency or iron-deficiency anemia

When testing supports iron deficiency, oral iron is commonly used because it is widely available and effective for many patients. The treatment plan depends on the severity of anemia, pregnancy status, the suspected cause, absorption, other medical conditions, and tolerance. A clinician may recommend an over-the-counter or prescription preparation, but the amount of elemental iron and treatment duration should reflect the diagnosis rather than the product’s marketing claims.

Follow-up matters. A response in hemoglobin and iron status can help confirm that treatment is working, while failure to improve may point to missed doses, continued bleeding, malabsorption, inflammation, another diagnosis, or a need for a different treatment. The British Society of Gastroenterology recommends early monitoring for response and intolerance; its guideline notes that lack of response has several possible causes and should not simply lead to indefinite self-treatment. ([British Society of Gastroenterology guideline](https://pmc.ncbi.nlm.nih.gov/articles/PMC8515119/))

Heavy menstrual bleeding

Iron can replace losses, but it does not stop heavy menstrual bleeding. Depending on the cause and a person’s reproductive goals, treatment may involve hormonal therapy, a levonorgestrel-releasing intrauterine device, nonhormonal medication, or evaluation for fibroids, polyps, endocrine conditions, or bleeding disorders. Recurrent iron deficiency despite supplementation is a reason to revisit the bleeding assessment.

Pregnancy or plans to become pregnant

The NIH lists a recommended dietary allowance of 18 milligrams of iron per day for nonpregnant women ages 19–50 and 27 milligrams during pregnancy. These are total daily intake targets from food and supplements, not instructions to self-prescribe a particular pill. ([NIH ODS](https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/))

ACOG’s pregnancy guidance recommends screening for anemia at the initial prenatal visit and again at 24–28 weeks. It distinguishes routine pregnancy supplementation from treatment of diagnosed iron-deficiency anemia, which may require more than a prenatal vitamin. ACOG’s guidance was reaffirmed in 2024. ([ACOG](https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2021/08/anemia-in-pregnancy))

The USPSTF’s August 20, 2024 statement is narrower: for asymptomatic pregnant people, it found insufficient evidence to determine whether routine screening or supplementation improves maternal or infant health outcomes. The Task Force did not frame this as evidence that iron is ineffective for people with anemia or confirmed deficiency. A pregnant person should therefore discuss prenatal and additional iron with an obstetric clinician rather than stopping or adding products based on a general headline. ([USPSTF](https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/iron-deficiency-anemia-in-pregnant-women-screening-and-supplementation))

Low ferritin with normal hemoglobin and fatigue

Iron deficiency can precede anemia, but fatigue is nonspecific. In one randomized trial, menstruating women with substantial unexplained fatigue, hemoglobin at least 12.0 g/dL, and ferritin below 50 micrograms per liter received 80 milligrams of elemental iron daily or placebo for 12 weeks. Fatigue improved more with iron, but the trial did not show significant improvements in quality of life, depression, or anxiety. The participants were selected carefully; the result does not establish that iron helps every tired person with a ferritin below 50. ([Randomized trial](https://pmc.ncbi.nlm.nih.gov/articles/PMC3414597/))

A separate Cochrane review of daily iron supplementation in menstruating women found improvements in hemoglobin and iron measures and possible improvement in fatigue, while also finding more gastrointestinal adverse effects. Taken together, this evidence supports a clinician-monitored approach for selected patients with low iron stores—not routine supplementation for fatigue without testing or a documented risk factor. ([Cochrane review](https://www.cochrane.org/evidence/CD009747_iron-supplementation-taken-daily-improving-health-menstruating-women))

When iron may not be the right choice

If hemoglobin and iron stores are normal and there is no special clinical reason to supplement, extra iron has no established predictable benefit. It may still cause nausea, constipation, abdominal pain, diarrhea, or other adverse effects. The NIH sets an adult tolerable upper intake level of 45 milligrams per day from all sources, although clinicians may temporarily prescribe more to treat documented deficiency. The upper limit is not a treatment dose, and prescribed treatment should not be compared with casual long-term use. ([NIH ODS—Consumer](https://ods.od.nih.gov/factsheets/Iron-Consumer/))

People with hereditary hemochromatosis, repeated transfusions, some liver conditions, or unexplained high ferritin should not start iron without medical guidance. The NIH notes that people with hemochromatosis are generally advised to avoid iron and vitamin C supplements unless directed otherwise. ([NIH ODS](https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/))

Do not use iron to explain away black stools, abdominal pain, unexplained weight loss, vomiting blood, blood in the stool, or new bleeding after menopause. Iron can darken stools, but that expected side effect should not be used to dismiss possible gastrointestinal bleeding.

GI side effects and dosing flexibility

Oral iron commonly causes constipation, nausea, abdominal discomfort, metallic taste, diarrhea, or heartburn. Tolerance depends on the formulation, elemental iron amount, schedule, food intake, and individual susceptibility. ([NIH ODS—Consumer](https://ods.od.nih.gov/factsheets/Iron-Consumer/))

Alternate-day dosing has attracted interest, but the evidence does not justify one universal schedule. In a 2023 randomized, double-blind trial of 150 young Swiss women with ferritin at or below 30 micrograms per liter, alternate-day dosing produced similar six-month ferritin levels at equal total iron exposure and fewer gastrointestinal side effects on iron-taking days. ([2023 randomized trial](https://pubmed.ncbi.nlm.nih.gov/38021373/))

Earlier randomized absorption studies found greater fractional and total absorption when iron was given on alternate rather than consecutive days, but those were absorption studies, not proof of superior long-term clinical outcomes. ([Absorption studies](https://pubmed.ncbi.nlm.nih.gov/29032957/))

Other trials have produced different results. A randomized trial in women with iron-deficiency anemia and hemoglobin between 6 and 10 g/dL reported a larger short-term hemoglobin increase and fewer adverse effects with alternate-day treatment, while a 2025 pilot trial in nonpregnant women with iron deficiency found greater improvement in some hematologic measures with daily dosing over 14 days. These studies differed in population, dose, duration, and outcomes, so they should not be used to prescribe a schedule for everyone. ([IDA randomized trial](https://pubmed.ncbi.nlm.nih.gov/40224710/); [2025 pilot trial](https://pubmed.ncbi.nlm.nih.gov/41354563/))

If side effects occur, ask a clinician or pharmacist whether changing the formulation, amount, schedule, or administration with food is reasonable. Taking iron with food may improve tolerance but can reduce absorption for some preparations. Follow-up testing helps determine whether the adjusted plan is effective.

Iron can also interfere with some medicines and supplements. Calcium, antacids, and iron can affect absorption of one another, and iron should be separated from levothyroxine according to the prescribing instructions. Iron may also interact with certain antibiotics and other medicines. A pharmacist can check the exact product list rather than relying on a generic spacing rule. ([MedlinePlus—Taking iron supplements](https://medlineplus.gov/ency/article/007478.htm); [MedlinePlus—Levothyroxine](https://medlineplus.gov/druginfo/meds/a682461.html))

How to assess an iron product

If a clinician recommends an over-the-counter product, focus on the label and the treatment goal:

• Check elemental iron. Different iron salts contain different proportions of elemental iron.
• Avoid duplicate exposure. Count iron from prenatal vitamins, multivitamins, fortified products, and separate supplements.
• Be cautious with marketing terms. “Gentle,” “natural,” or “high absorption” does not establish clinical superiority for your diagnosis.
• Use quality information appropriately. Independent testing may assess identity or contaminants, but it does not prove that the product will correct a deficiency.
• Understand FDA oversight. FDA does not approve dietary supplements for safety and effectiveness before they are sold, unlike approved prescription and over-the-counter drugs. ([FDA](https://www.fda.gov/consumers/consumer-updates/fda-101-dietary-supplements))

Solid oral iron-containing dietary supplements must carry a specific warning because accidental overdose can be fatal in young children. ([FDA iron-labeling guidance](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-label-warning-statements-iron-containing-supplements-and-drugs))

Safety and red flags

Store iron-containing products, including prenatal vitamins, out of children’s reach. After a suspected ingestion in the United States, call Poison Help at 1-800-222-1222; call 911 for collapse, seizure, trouble breathing, or inability to wake the person. Iron poisoning can cause vomiting, abdominal pain, diarrhea, gastrointestinal bleeding, low blood pressure, organ injury, coma, or death. ([MedlinePlus](https://medlineplus.gov/ency/article/002659.htm); [FDA](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-label-warning-statements-iron-containing-supplements-and-drugs))

Seek prompt care for severe shortness of breath, chest pain, fainting, heavy uncontrolled bleeding, vomiting blood, blood in the stool, or new bleeding after menopause. These symptoms require evaluation rather than an over-the-counter supplement experiment.

A practical decision framework

Step 1: Identify the context. Consider pregnancy, plans for pregnancy, heavy periods, recent childbirth, frequent blood donation, a restrictive diet, gastrointestinal symptoms, or a history of anemia.

Step 2: Review symptoms without assuming the cause. Fatigue, headache, restless legs, pale skin, breathlessness, and reduced exercise tolerance can occur with iron deficiency but are not specific.

Step 3: Ask whether testing is appropriate. A CBC and ferritin are common starting points. If inflammation or chronic disease is possible, additional iron studies may be needed.

Step 4: Look for the cause. Heavy bleeding, inadequate intake, malabsorption, and gastrointestinal blood loss require different responses.

Step 5: Use a monitored treatment plan. Product, elemental iron amount, schedule, duration, and follow-up should reflect the diagnosis and tolerance.

Step 6: Reassess before continuing indefinitely. Iron needs can change after pregnancy, menopause, treatment of heavy bleeding, dietary changes, or correction of an absorption problem.

What is well supported—and what remains uncertain

The evidence supports iron treatment for confirmed iron deficiency and iron-deficiency anemia. It also supports closer assessment of people with heavy menstrual bleeding, pregnancy-related risk, inadequate intake, frequent blood donation, or possible malabsorption.

Less certain questions include the best ferritin threshold for every nonanemic woman, the value of treating low ferritin without anemia in people who do not have fatigue or another relevant symptom, the ideal oral dosing schedule for all forms of deficiency, and whether routine screening or supplementation improves outcomes in asymptomatic pregnant people. The USPSTF’s August 20, 2024 I statement addresses that last question; ACOG’s pregnancy guidance provides a separate clinical framework for screening and care.

Uncertainty is a reason to individualize decisions and arrange follow-up—not a reason to dismiss documented deficiency or to take high-dose iron indefinitely without a diagnosis.

Reader FAQs

Should every woman who has periods take iron?

No. Menstruation increases risk, but it does not prove deficiency. Testing is more worth discussing when bleeding is heavy, fatigue persists, diet is low in iron, blood donation is frequent, or another risk factor is present.

Can iron deficiency occur when hemoglobin is normal?

Yes. Iron stores can fall before anemia develops. Ferritin and, when needed, additional iron studies can help clarify the situation. A normal hemoglobin should not automatically end the evaluation when risk factors or symptoms are meaningful.

Is a prenatal vitamin enough during pregnancy?

It may provide routine prenatal iron, but products differ and the right plan depends on laboratory results, diet, tolerance, and medical history. Diagnosed iron deficiency or anemia may require additional treatment. Discuss changes with the prenatal-care clinician.

What should I do if iron causes constipation or nausea?

Contact a clinician or pharmacist before stopping. They may adjust the product, amount, schedule, or instructions for taking it with food. Seek urgent help after a suspected overdose or for severe abdominal symptoms, vomiting blood, collapse, or breathing difficulty.

Final summary

Women are more likely to become iron deficient when menstrual or pregnancy-related needs combine with heavy bleeding, inadequate intake, blood donation, impaired absorption, or another source of blood loss. But the useful question is not simply, “Do I menstruate?” It is, “Do I have evidence of deficiency, a meaningful risk factor, or a life stage that changes my iron needs?”

For many adults, the safest approach is to assess the cause, use appropriate laboratory testing, choose a tolerable treatment when indicated, and confirm the response. Iron can be highly effective when it is needed—and unnecessary, uncomfortable, or dangerous when it is not.